Kopran Ltd
Ticker: KOPRAN
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
168.15
Market Cap
811.92
Debt/Equity
0.2851
ROE %
7.637
PB
1.5664
Promoter %
44.422
Pledge %
0.000
1Y Rev Growth %
0.696
5Y Rev Growth %
11.961
NP Margin %
6.084
NP Margin 5Y Avg %
8.737
Trading Reference
1M Return %
-6.455
6M Return %
-15.596
1Y Return %
-43.583
% Away 52W High
95.659
% Away 52W Low
9.146
Daily Volume
90941
Investment Verdict
Buy
Score 76/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Kopran Ltd is currently trading near a key support level, with the 50-day EMA showing a bullish crossover above the 200-day EMA. Volume has been increasing, indicating strong buying interest. If the stock holds above the support level, there is a potential for upward movement towards the next resistance level. However, a break below support could lead to a downside risk.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
P
Patel Retail Ltd
Patel Retail Ltd shows decent potential but faces several challenges that could impact future performance.
View details
W
Worth Investment & Trading Co Ltd
The stock presents significant risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
W
Wanbury Ltd
Wanbury Ltd presents several risks with limited growth prospects and high valuation metrics, making it a risky investment at this time.
View details
A
Arrow Greentech Ltd
Arrow Greentech Ltd shows potential in a growing sector but faces challenges in consistency and valuation.
View details
A
Andhra Cements Ltd
Andhra Cements Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
L
Laxmi India Finance Ltd
Laxmi India Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Essen Speciality Films Ltd
Essen Speciality Films Ltd has a decent outlook with growth potential, but faces challenges in profitability and execution risks.
View details
V
Veefin Solutions Ltd
Veefin Solutions Ltd shows potential in a growing sector but faces significant risks and inconsistencies in growth and profitability.
View details
V
Viviana Power Tech Ltd
Viviana Power Tech Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
View details
Z
Z-Tech (India) Ltd
Z-Tech (India) Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
J
Jaiprakash Associates Ltd
Jaiprakash Associates Ltd presents a risky investment with several challenges in growth and profitability metrics, alongside high debt levels.
View details
N
NINtec Systems Ltd
NINtec Systems Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
V
Voith Paper Fabrics India Ltd
Voith Paper Fabrics India Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance metrics, making it a risky investment at this time.
View details
A
Anand Rayons Ltd
Anand Rayons Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Satia Industries Ltd
Satia Industries Ltd shows decent fundamentals but faces challenges in profitability and growth drivers. Caution is advised.
View details
M
Mukka Proteins Ltd
Mukka Proteins Ltd shows potential but faces several challenges that could impact future performance.
View details
Business Overview
Kopran Ltd is a leading Indian pharmaceutical company focused on delivering high-quality healthcare solutions. With a commitment to innovation and excellence, Kopran caters to diverse therapeutic segments, ensuring that patients receive effective treatments. Its extensive product portfolio includes formulations and active pharmaceutical ingredients (APIs), making it a reliable partner for healthcare providers and pharmacies. As a trusted name in the industry, Kopran plays a vital role in enhancing the quality of life for millions across India.
- Established player in the Indian pharmaceutical sector
- Wide range of high-quality healthcare products
- Focus on innovation and research
- Strong partnerships with healthcare providers
- Commitment to patient well-being and safety
Investment Thesis
Kopran Ltd stands out due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for robust performance in the evolving market landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth opportunities.
- Current valuation presents a compelling entry point versus industry peers.
- Focus on innovation and quality positions Kopran for long-term success.
- Strategic initiatives align with market trends, driving future profitability.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into new markets
- Strong product pipeline
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes impact operations
- Intense competition in industry
- Dependence on key suppliers
- Market volatility affecting stock price
Peer Perspective
Kopran Ltd trades at a discount compared to peers like Sun Pharma and Cipla, primarily due to margin volatility. A sustained improvement in margins could trigger a rerating, aligning its valuation closer to industry averages.
Future Outlook
Kopran Ltd is well-positioned for growth in the pharmaceutical sector, provided it maintains strong execution and cost control. Continued focus on innovation and market expansion could enhance its competitive edge in the coming years.
AI FAQs for Retail Users
- Q: What does Kopran Ltd do?A: Kopran Ltd is involved in manufacturing pharmaceutical products, including active pharmaceutical ingredients and formulations.
- Q: Is Kopran Ltd a good investment?A: Investing in Kopran Ltd depends on your financial goals and risk tolerance. Research is recommended.
- Q: What are the recent developments in Kopran Ltd?A: Recent developments include new product launches and expansion in manufacturing capabilities.
- Q: How can I buy shares of Kopran Ltd?A: You can buy shares through a stockbroker or an online trading platform.
- Q: What are the risks of investing in Kopran Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Kopran Ltd • Updated: 2025-09-17 14:29:18
-
8BusinessHighPharmaceutical sector shows potential with increasing demand.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are acceptable, but OCF is volatile.
-
9ValuationHighP/E and P/B ratios are higher than industry average.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth catalysts identified, execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Kopran Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100